Bridgeway Capital Management, LLC Olema Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$8.19 - $12.98 $239,148 - $379,016	-29,200 Reduced 25.24%	86,487 $1.07 Million
Q1 2023 May 15, 2023	SELL	$2.55 - $4.97 $56,099 - $109,340	-22,000 Reduced 15.98%	115,687 $401,000
Q4 2022 Feb 14, 2023	BUY	$2.27 - $3.76 $18,387 - $30,456	8,100 Added 6.25%	137,687 $337,000
Q3 2022 Nov 14, 2022	BUY	$2.72 - $5.88 $352,476 - $761,971	129,587 New	129,587 $358,000

160

67.7M

235K

1.3K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $179M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.